80 FR 9267 - Sunshine Act Meeting

FEDERAL DEPOSIT INSURANCE CORPORATION

Federal Register Volume 80, Issue 34 (February 20, 2015)

Page Range		9267-9267
FR Document		2015-03605

Federal Register, Volume 80 Issue 34 (Friday, February 20, 2015)

[Federal Register Volume 80, Number 34 (Friday, February 20, 2015)]
[Notices]
[Page 9267]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-03605]


=======================================================================
-----------------------------------------------------------------------

FEDERAL DEPOSIT INSURANCE CORPORATION


Sunshine Act Meeting

    Pursuant to the provisions of the ``Government in the Sunshine 
Act'' (5 U.S.C. 552b), notice is hereby given that at 10:03 a.m. on 
Tuesday, February 17, 2015, the Board of Directors of the Federal 
Deposit Insurance Corporation met in closed session to consider matters 
related to the Corporation's supervision, corporate, and resolution 
activities.
    In calling the meeting, the Board determined, on motion of Vice 
Chairman Thomas M. Hoenig, seconded by Director Jeremiah O. Norton 
(Appointive), concurred in by Director Thomas J. Curry (Comptroller of 
the Currency), Director Richard Cordray (Director, Consumer Financial 
Protection Bureau), and Chairman Martin J. Gruenberg, that Corporation 
business required its consideration of the matters which were to be the 
subject of this meeting on less than seven days' notice to the public; 
that no earlier notice of the meeting was practicable; that the public 
interest did not require consideration of the matters in a meeting open 
to public observation; and that the matters could be considered in a 
closed meeting by authority of subsections (c)(4), (c)(6), (c)(8), 
(c)(9)(A)(ii), and (c)(9)(B) of the ``Government in the Sunshine Act'' 
(5 U.S.C. 552b(c)(4), (c)(6), (c)(8), (c)(9)(A)(ii), and (c)(9)(B).
    The meeting was held by telephone.

    Dated: February 17, 2015.

Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
[FR Doc. 2015-03605 Filed 2-18-15; 4:15 pm]
BILLING CODE 6714-01-P

Federal Register / Vol. 80, No. 34 / Friday, February 20, 2015 / Notices 9267

Management Plan to Reduce Predation compliance with the Administrative Federal Deposit Insurance Corporation.
of Juvenile Salmonids in the Columbia Procedure Act. Robert E. Feldman,
River Estuary, Review Period Ends: 03/ DATES:This action is effective as of Executive Secretary.
16/2015, Contact: Robert Winters 503– February 5, 2015. [FR Doc. 2015–03605 Filed 2–18–15; 4:15 pm]
808–4738. Revision to FR Notice BILLING CODE 6714–01–P
Published 02/13/2015; Correction to ADDRESSES: Copies of the petition
Document Status should be Final EIS. reissuance and all pertinent information
relating thereto are on file at the
Dated: February 17, 2015. DEPARTMENT OF HEALTH AND
following location: Environmental
Dawn Roberts,
Protection Agency, Region 6, Water HUMAN SERVICES
Management Analyst, NEPA Compliance Quality Protection Division, Source
Division, Office of Federal Activities. Food and Drug Administration
Water Protection Branch (6WQ–S), 1445
[FR Doc. 2015–03524 Filed 2–19–15; 8:45 am] Ross Avenue, Dallas, Texas 75202–2733. [Docket No. FDA–2015–D–0349]
BILLING CODE 6560–50–P
FOR FURTHER INFORMATION CONTACT: Investigating and Reporting Adverse
Philip Dellinger, Chief Ground Water/ Reactions Related to Human Cells,
ENVIRONMENTAL PROTECTION UIC Section, EPA—Region 6, telephone Tissues, and Cellular and Tissue-
AGENCY (214) 665–8324. Based Products; Draft Guidance for
[FRL–9922–98–Region 6] Dated: February 5, 2015. Industry; Availability
William K. Honker, AGENCY: Food and Drug Administration,
Underground Injection Control Director, Water Quality Protection Division. HHS.
Program; Hazardous Waste Injection [FR Doc. 2015–03463 Filed 2–19–15; 8:45 am] ACTION: Notice.
Restrictions; Petition for Exemption BILLING CODE 6560–50–P
Reissuance—Class I Hazardous Waste SUMMARY: The Food and Drug
Injection; Lucite International, Inc. Administration (FDA) is announcing the
Beaumont Site, Nederland, TX availability of a draft document entitled
AGENCY: Environmental Protection FEDERAL DEPOSIT INSURANCE ‘‘Investigating and Reporting Adverse
Agency (EPA). CORPORATION Reactions Related to Human Cells,
Tissues, and Cellular and Tissue-Based
ACTION: Notice of a final decision on a Sunshine Act Meeting Products (HCT/Ps) Regulated Solely
no migration petition reissuance. Under Section 361 of the Public Health
Pursuant to the provisions of the Service Act and 21 CFR part 1271’’
SUMMARY: Notice is hereby given that a ‘‘Government in the Sunshine Act’’ (5
reissuance of an exemption to the land dated February 2015. The draft guidance
U.S.C. 552b), notice is hereby given that document is intended to provide
disposal Restrictions, under the 1984 at 10:03 a.m. on Tuesday, February 17,
Hazardous and Solid Waste manufacturers of human cells, tissues,
2015, the Board of Directors of the and cellular and tissue-based products
Amendments to the Resource Federal Deposit Insurance Corporation
Conservation and Recovery Act, has (HCT/Ps) for which no premarket
met in closed session to consider submissions are required because they
been granted to Lucite International, matters related to the Corporation’s
Inc. for two Class I hazardous injection are not also regulated as drugs, devices,
supervision, corporate, and resolution and/or biological products, with
wells located at their Beaumont site activities.
located in Nederland, TX. The company recommendations for complying with
In calling the meeting, the Board the requirements for investigating and
has adequately demonstrated to the
determined, on motion of Vice reporting adverse reactions involving
satisfaction of the Environmental
Chairman Thomas M. Hoenig, seconded communicable disease in recipients of
Protection Agency by the petition
by Director Jeremiah O. Norton these HCT/Ps. The draft guidance, when
reissuance application and supporting
(Appointive), concurred in by Director finalized, is intended to supplement
documentation that, to a reasonable
Thomas J. Curry (Comptroller of the section XXII of FDA’s guidance entitled
degree of certainty, there will be no
Currency), Director Richard Cordray ‘‘Guidance for Industry: Current Good
migration of hazardous constituents
(Director, Consumer Financial Tissue Practice (CGTP) and Additional
from the injection zone for as long as the
Protection Bureau), and Chairman Requirements for Manufacturers of
waste remains hazardous. This final
Martin J. Gruenberg, that Corporation Human Cells, Tissues, and Cellular and
decision allows the continued
business required its consideration of Tissue-Based Products (HCT/Ps)’’ dated
underground injection by Lucite, of the
the matters which were to be the subject December 2011 and supersede the
specific restricted hazardous wastes
of this meeting on less than seven days’ guidance entitled ‘‘Guidance for
identified in this exemption reissuance,
notice to the public; that no earlier Industry: MedWatch Form FDA 3500A:
into Class I hazardous waste injection
notice of the meeting was practicable; Mandatory Reporting of Adverse
wells WDW–100 & 101 until December
that the public interest did not require Reactions Related to Human Cells,
31, 2030, unless EPA moves to
consideration of the matters in a Tissues, and Cellular and Tissue-Based
terminate this exemption. Additional
meeting open to public observation; and Products (HCT/Ps)’’ dated November
conditions included in this final
that the matters could be considered in 2005.
decision may be reviewed by contacting
a closed meeting by authority of
the Region 6 Ground Water/UIC Section. DATES: Although you can comment on
TKELLEY on DSK3SPTVN1PROD with NOTICES

subsections (c)(4), (c)(6), (c)(8),
A public notice was issued December any guidance at any time (see 21 CFR
(c)(9)(A)(ii), and (c)(9)(B) of the
18, 2014. The public comment period 10.115(g)(5)), to ensure that the Agency
‘‘Government in the Sunshine Act’’ (5
closed on February 2, 2015. No considers your comment on this draft
U.S.C. 552b(c)(4), (c)(6), (c)(8),
comments were received. This decision guidance before it begins work on the
(c)(9)(A)(ii), and (c)(9)(B).
constitutes final Agency action and final version of the guidance, submit
there is no Administrative appeal. This The meeting was held by telephone. either electronic or written comments
decision may be reviewed/appealed in Dated: February 17, 2015. on the draft guidance by April 21, 2015.

VerDate Sep<11>2014 17:07 Feb 19, 2015 Jkt 235001 PO 00000 Frm 00008 Fmt 4703 Sfmt 4703 E:\FR\FM\20FEN1.SGM 20FEN1

Document Created: 2015-12-18 13:02:03
Document Modified: 2015-12-18 13:02:03

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		80 FR 9267